Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.955 SEK | +2.25% | -26.12% | -61.42% |
04-15 | Oncopeptides AB Secures National Reimbursement for Pepaxti in Spain | CI |
04-04 | Oncopeptides AB Provides Sales Guidance for the First Quarter of 2024 | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- ONCO Stock
- Revisions Oncopeptides AB